Defiance Daily Target 2X Long LLY ETF (LLYX)

NYSEARCA: LLYX · Real-Time Price · USD
26.91
-0.75 (-2.72%)
Sep 26, 2024, 3:59 PM EDT - Market closed
-2.72%
Assets $5.53M
Expense Ratio 1.29%
PE Ratio n/a
Shares Out 200,000
Dividend (ttm) n/a
Dividend Yield n/a
Ex-Dividend Date n/a
Payout Ratio n/a
1-Year Return n/a
Volume 11,625
Open 27.22
Previous Close 27.66
Day's Range 26.54 - 27.30
52-Week Low 22.96
52-Week High 31.19
Beta n/a
Holdings n/a
Inception Date Aug 7, 2024

About LLYX

Fund Home Page

The Defiance Daily Target 2X Long LLY ETF (LLYX) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide 2x leveraged exposure to the daily share price movement of the Eli Lilly and Company (NYSE: LLY), less fees and expenses. LLYX was launched on Aug 7, 2024 and is issued by Defiance.

Asset Class Equity
Stock Exchange NYSEARCA
Ticker Symbol LLYX
ETF Provider Defiance

News

Defiance Lists Leveraged Eli Lilly ETF

On Thursday, Defiance ETFs rolled out its next leveraged fund, the Defiance Daily Target 2X Long LLY ETF (LLYX). The actively managed LLYX has a net expense ratio of 1.29%.

7 weeks ago - ETF Trends